tiprankstipranks
Advertisement
Advertisement

Wellgistics Health Expands Digital Health Partnership and Strategy

Story Highlights
  • A Florida court approved a stock-for-debt settlement letting Wellgistics retire over $10.7 million in liabilities through share issuances, potentially diluting existing investors.
  • Wellgistics expanded its Tollo Health partnership to add telehealth and mental health AI services, supporting GLP-1, Long COVID, and chronic-care patients as it pivots toward a broader digital health model.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Wellgistics Health Expands Digital Health Partnership and Strategy

Meet Samuel – Your Personal Investing Prophet

The latest announcement is out from Wellgistics Health Inc ( (WGRX) ).

On February 4, 2026, Wellgistics Health Inc. obtained a Florida court order approving a settlement agreement under Section 3(a)(10) of the Securities Act that allows Silverback Capital Corporation to receive shares of Wellgistics common stock in exchange for acquiring and settling at least $10.7 million of the company’s liabilities. The stock will be issued in tranches at fixed prices between $0.25 and $2.25 per share, including additional shares for settlement and legal fees, with a February 9 amendment locking in a $0.25 price for the first $2.25 million tranche, a move that restructures debt but could significantly dilute existing shareholders.

Separately, on February 6, 2026, Wellgistics entered a consulting agreement with Fortitude Advisors, appointing its owner Gerald Commissiong as consulting chief business officer to support business development. On February 11, 2026, the company expanded its partnership with Tollo Health, adding telehealth and mental health AI capabilities through TolloCare to serve GLP-1, Long COVID, and broader chronic-condition patients, aligning with Wellgistics’ shift from pure pharmaceutical distribution toward a tech-enabled, online care model that may enhance its competitive position in digital health and telemedicine.

More about Wellgistics Health Inc

Wellgistics Health Inc., listed on Nasdaq as WGRX, is a health information technology company that integrates its proprietary EinsteinRx AI pharmacy dispensing optimization engine with its patented blockchain-enabled PharmacyChain smart contracts platform to streamline the U.S. prescription drug journey. The company connects more than 6,500 pharmacies and over 200 manufacturers, offering wholesale distribution, digital prescription routing, direct-to-patient delivery, and AI-powered hub services to improve access, transparency, and fulfillment for independent pharmacies.

Average Trading Volume: 599,117

Technical Sentiment Signal: Strong Sell

Current Market Cap: $28.15M

See more data about WGRX stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1